G
Guest
This site is fantastic. I've taken some time to read the various perspectives and would greatly appreciate the collective experience and knowledge on my case. I apologize for the length of this post in advance. At my annual physical, my doctor detected a murmur which turned out to be aortic regurgitation. I’m otherwise very healthy. The left ventricle has increased its size, but not so much that heart can't resume normal function with a functional aortic valve. After my TEE, it was determined that I have a prolapsed leaflet that one of my surgeons said is 90% repairable. He also said that the repair could last from 5 years to life. I've done some research on the repair (Commissural Annuloplasty with some form of tri-leaflet plication, the surgeon compared it to reefing a sail) and the data support his percentages. I'm now trying to evaluate which hospital (both Boston based), Brigham and women's ranked by US News as #4 nationally and Lahey, which has a really good surgeon and well regarded valve replacement clinic. Also, I need to determine what valve to go with in the case I'm hit with the 10% of repair failure. I know there are some strong opinions out there and I welcome them all. Here are my thoughts:
Mechanical Valve
On-X seems to have the lowest required INR and good outcomes - Brigham would use On-x and Lahey would only use Top Hat
Mechanical valve requires only one Open Heart Surgery and would last for life.
Life on Coumadin – One surgeon said that my daily one whiskey (or two) would have to go due to potential liver impact. He said that going on Coumadin while young generally produced excellent adaptation and aortic thrombotic event risk would be very low with the mech valve.
Bio Valve
Lahey would use the Medtronic Freestyle or the Magna Ease (Edwards Lifesciences)
Brigham indicated only a bovine valve
Bio Valve would require another procedure:
- One surgeon indicated that when the initial valve fails, regulations will likely to have changed to allow TAVR in a healthy 65 year old (guess at when the procedure would be required)
- The other surgeon indicated only that current rules would not allow a TAVR in an otherwise healthy 65 year old
The newer valves are lasting significantly longer than the older versions (The Magna Ease lasted over 17 years in patients less than 60 years old in the aortic position and 16 years in the mitral position – evaluated over a 25 year period equivalent to 3,300 valve years (this data is from the company so I view with some cynicism).
The third procedure would definitely be a valve in valve procedure. The TAVRs are improving radically over time and are nearing the durability and hemodynamics of bio valve replacements. In 15 years (or 20 if I’m lucky), they will have improved even further.
Evaluation
Risk of mech valve annual stroke or thrombotic event annually is approx. 1%
Risk of infection (endocarditis) is lower with the mechanical valve than bio valve
Risk of bleeding event is higher with Mechanical valve than with bio valve
There was some mention of neurological issues with Coumadin. I know of two friend’s fathers, both on Coumadin, both had a fall (while walking) with moderate head impact and subsequent intracranial hemorrhage requiring surgery.
Conclusion
All in all, it seems that the annual risks are higher for the mechanical valves. The event risk associated with the bio valves is significant, but less than the cumulative risks for mechanical valves. Open heart surgery scares the daylights out of me. But, so does the risk of stroke and intracranial bleeding. One surgeon said that the bio valve was the way to go, with subsequent TAVRs. The other said that it was 50/50 and a very hard choice. My take was that he viewed the change in regulation to allow for TAVRs was a significant risk.
I’m leaning towards a bio valve and towards Brigham. But, I like the Lahey surgeon a lot. I would also go for the On-X in the case of Mechanical or Magna Ease in the case of bio valve. (We discussed the St. Jude Trifecta and there were some initial problems and not enough history for the surgeon to go with that option). Apologies for the length of the above. Research is how I respond to terror and I’m terrified. Thank you very much in advance for your help. I have my last meeting with my surgeon tomorrow and then I have to decide.
Mechanical Valve
On-X seems to have the lowest required INR and good outcomes - Brigham would use On-x and Lahey would only use Top Hat
Mechanical valve requires only one Open Heart Surgery and would last for life.
Life on Coumadin – One surgeon said that my daily one whiskey (or two) would have to go due to potential liver impact. He said that going on Coumadin while young generally produced excellent adaptation and aortic thrombotic event risk would be very low with the mech valve.
Bio Valve
Lahey would use the Medtronic Freestyle or the Magna Ease (Edwards Lifesciences)
Brigham indicated only a bovine valve
Bio Valve would require another procedure:
- One surgeon indicated that when the initial valve fails, regulations will likely to have changed to allow TAVR in a healthy 65 year old (guess at when the procedure would be required)
- The other surgeon indicated only that current rules would not allow a TAVR in an otherwise healthy 65 year old
The newer valves are lasting significantly longer than the older versions (The Magna Ease lasted over 17 years in patients less than 60 years old in the aortic position and 16 years in the mitral position – evaluated over a 25 year period equivalent to 3,300 valve years (this data is from the company so I view with some cynicism).
The third procedure would definitely be a valve in valve procedure. The TAVRs are improving radically over time and are nearing the durability and hemodynamics of bio valve replacements. In 15 years (or 20 if I’m lucky), they will have improved even further.
Evaluation
Risk of mech valve annual stroke or thrombotic event annually is approx. 1%
Risk of infection (endocarditis) is lower with the mechanical valve than bio valve
Risk of bleeding event is higher with Mechanical valve than with bio valve
There was some mention of neurological issues with Coumadin. I know of two friend’s fathers, both on Coumadin, both had a fall (while walking) with moderate head impact and subsequent intracranial hemorrhage requiring surgery.
Conclusion
All in all, it seems that the annual risks are higher for the mechanical valves. The event risk associated with the bio valves is significant, but less than the cumulative risks for mechanical valves. Open heart surgery scares the daylights out of me. But, so does the risk of stroke and intracranial bleeding. One surgeon said that the bio valve was the way to go, with subsequent TAVRs. The other said that it was 50/50 and a very hard choice. My take was that he viewed the change in regulation to allow for TAVRs was a significant risk.
I’m leaning towards a bio valve and towards Brigham. But, I like the Lahey surgeon a lot. I would also go for the On-X in the case of Mechanical or Magna Ease in the case of bio valve. (We discussed the St. Jude Trifecta and there were some initial problems and not enough history for the surgeon to go with that option). Apologies for the length of the above. Research is how I respond to terror and I’m terrified. Thank you very much in advance for your help. I have my last meeting with my surgeon tomorrow and then I have to decide.